CTRI/2023/04/051786已完成Unknown
A post-marketing surveillance multi-centric study to evaluate quality, safety and performance of VELFIX® EDGE plus CHG a cannula securement patch dressing in Reducing catheter Related Bloodstream Infection.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 2
- 主要终点
- Detection of colonized of microorganisms Through a Swab test at the Catheter Patch
研究概览
简要总结
It comprises a transparent adhesive dressing to act as a barrier against external contamination and an integrated gel pad containing an antiseptic agent. VELFIX® EDGE + CHG cannula securement dressing is associated with lower incidence of catheter related infection, and reduction in dermatitis incidence, related to the application of VELFIX® EDGE + CHG cannula securement dressing.
300 Subjects will be enrolled.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Male and female in the Age group of 18 to 70 years both included.
- •2.Hospitalized, ICU and Non-ICU patients.
- •3.Clinical indication for the insertion of a non-tunneled central venous catheter (excluding large bore catheters for dialysis or pheresis) or a PICC 4.Patients catheterized for, Central venous Dialysis, Broviac catheters, Epidural, Arterial, Peripheral/Midline venous catheters/ cannula that shall stay for a minimum duration of 96 hours.
- •5.Include femoral vein catheter insertion patients.
排除标准
- •1.Age < 18 years & more than 70 yrs. 2.Inability to obtain an informed consent. 3.Actual evidence.
- •or recent history (< 30 days).
- •of bloodstream infection. 4.Specific intolerance or known hypersensitivity to transparent dressings or to chlorhexidine. 5.Patients with critical illness vital organ dysfunction 6.Threatened airway 7.All respiratory arrests 8.Respiratory rate ⩾40 or ⩽8 breaths/min 9.Oxygen saturation <90% on ⩾50% oxygen 10.All cardiac arrests 11.Pulse rate <40 or >140 beats/min 12.Systolic blood pressure <90 mm Hg 13.Sudden fall in level of consciousness (fall in Glasgow coma score >2 points) 14.Repeated or prolonged seizures 15.Rising arterial carbon dioxide tension with respiratory acidosis 16.Any patient giving cause for concern 17.Use of anti-bacterial treated catheters, i.e., catheters coated with antibacterial drugs as well as catheters whose polyurethane releases ions with potential antiseptic action. 18.Any form of dermatitis, burns, skin lesions or tattoos at the insertion site. 19.Use of topical antibiotics within a 10cm of the catheter insertion site. 20.Enrolment in another investigational drug or device study at any time during this study or 30 days prior.
结局指标
主要结局
Detection of colonized of microorganisms Through a Swab test at the Catheter Patch
时间窗: Up-to 7 days
Insertion Site
时间窗: Up-to 7 days
次要结局
- Study participants having hypersensitivity to VELFIX® EDGE plus CHG cannula securement patch dressing.(Study participants having dermatitis at the site of catheter insertion.)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean ChildrenHaemophilus Influenzae Type B InfectionNCT01404962Novartis Vaccines764
已完成
Unknown
A study to evaluate the safety and effect of Ropin Heavy® injection for spinal anaesthesia in adult subjectsAdministration,CTRI/2022/03/040917Neon Laboratories Ltd214
终止
不适用
A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckUnresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckLA SCCHNNCT01303237Merck KGaA, Darmstadt, Germany88
已完成
不适用
HEPSERA Post Marketing SurveillanceHepatitis BNCT01329419GlaxoSmithKline4,393
撤回
4 期
Travacom Post Marketing Surveillance StudyOcular HypertensionOpen-angle GlaucomaNCT01510132Alcon Research